bromopyruvate has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibrahim, WM; Mansour, MA; Salama, AF; Salama, MM | 1 |
| Dell'Antone, P | 1 |
2 other study(ies) available for bromopyruvate and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Dual inhibition of glycolysis and autophagy as a therapeutic strategy in the treatment of Ehrlich ascites carcinoma.
Topics: Animals; Antineoplastic Agents; Antioxidants; Autophagy; Carcinoma, Ehrlich Tumor; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Glycolysis; Hexokinase; Hydroxychloroquine; Kupffer Cells; Liver; Mice; Mice, Inbred BALB C; Oxidative Stress; Pyruvates | 2020 |
Inactivation of H+-vacuolar ATPase by the energy blocker 3-bromopyruvate, a new antitumour agent.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Energy Metabolism; Enzyme Inhibitors; Hydrogen-Ion Concentration; Liver; Lysosomes; Mice; Pyruvates; Rats; Thymus Gland; Tumor Cells, Cultured; Vacuolar Proton-Translocating ATPases | 2006 |